Skip to main content

Table 1 Clinical and pathological data of sporadic AD cases and non-demented controls. Aβ staining intensity: - no staining; (+) barely detectable staining, + weak staining, ++ moderate staining, +++ abundant staining; NP neuritic plaques

From: Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer’s disease and transgenic mouse models

      

4G8

Aβ37

Aβ38

Aβ39

Aβ40

No.

Age

Sex

Braak

Diagnosis

ApoE

NP

CAA

NP

CAA

NP

CAA

NP

CAA

NP

CAA

#1

92

M

IV

AD

3/3

++

+

-

-

-

+

-

+

+

+

#2

92

F

IV

AD

3/3

+

++

-

-

-

+

-

-

+

+

#3

93

M

IV

AD

3/3

+

+++

-

+++

-

++

-

++

++

+++

#4

91

M

IV

AD

4/2

++

+++

-

+

-

+

-

-

++

+++

#5

84

F

IV

AD

4/3

++

+

-

+

-

++

-

++

+

++

#6

91

F

IV

AD

4/3

++

++

-

++

(+)

+

-

+

++

+++

#7

88

F

IV

AD

3/3

+

+

-

-

-

-

-

-

+

+

#8

92

F

IV

AD

4/2

++

++

-

+

(+)

+

-

+

+

++

#9

79

F

IV

AD

4/3

++

+++

(+)

++

(+)

+++

-

++

++

+++

#10

84

F

IV

AD

3/2

++

-

-

-

-

-

-

-

+

-

#11

91

F

IV

AD

4/3

++

+

-

(+)

-

-

-

(+)

(+)

+

#12

86

M

IV

AD

3/3

+

++

-

+++

-

++

-

+++

+

++

#13

88

F

IV

AD

3/3

++

+

-

-

-

-

-

-

-

+

#14

96

F

V

AD + CAA

4/3

++

+++

-

+

-

+++

-

++

++

+++

#15

82

F

V

AD + CAA

3/3

++

+++

-

++

-

+++

+

+++

+++

+++

#16

61

F

VI

DS

3/3

++

-

-

-

-

-

-

-

+

-

#17

58

M

VI

DS

4/3

++

++

(+)

+

+

+

-

-

++

++

#18

64

F

V

DS

3/3

++

++

-

++

-

++

-

++

++

++

#19

91

M

I

NDC

3/3

-

-

-

-

-

-

-

-

-

-

#20

78

F

I

NDC

3/3

(+)

-

-

-

-

-

-

-

-

+

#21

73

M

0

NDC

3/3

-

-

-

-

-

-

-

-

-

-

#22

84

M

I

NDC

3/3

-

-

-

-

-

-

-

-

-

-

#23

88

F

I

NDC

3/3

+

-

-

-

-

-

-

-

-

-

#24

78

M

I

NDC

4/3

++

+

-

-

-

+

-

-

+

++

#25

82

F

I

NDC

3/3

-

-

-

-

-

-

-

-

-

-

#26

70

M

0

NDC

3/2

-

-

-

-

-

-

-

-

-

-